Investments
 Back to Home

FemSelect is a developer of medical devices designed to treat pelvic organ prolapse disease in women. The company's devices offer a minimally-invasive surgical system for suturing ligaments of the pelvic floor without overnight hospital stays and scars, enabling physicians to conduct surgery without dissection or mesh.

Investment: Series B (Lead)

Insert your text here
​​521 Fifth Avenue, Floor 17
​​​​​​​New York, NY 10175
© 2022 New Age Ventures LLC